Use of g-rich oligonucleotides for treating neoplastic diseases
BRPI0817712A2
5,6-Dimethyl-oxo-xanthan-4-acetic acid crystalline sodium salt, crystalline form thereof, processes for preparing 5,6-dimethyl-oxo-xanthan-4-acetic acid crystalline sodium salt, and, for preparing crystalline form, pharmaceutical composition, method for preparing a pharmaceutical composition, use of a dmxaa crystalline sodium salt, method for treating cancer, parts kit, and, pharmaceutical formulation
GB0808956D0
Treatment of paediatric cancers
GB0802075D0
Biological materials and uses thereof
EP2117548A1
Method of treating multidrug resistant cancers
US2009131351A1
Methods, compositions, and kits for modulating tumor cell proliferation
US2008318889A1
Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
US2011178161A1
Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
US2008318890A1
Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
GB0517387D0
Combinations for the treatment of cancer
GB0517386D0
Combinations for the treatment of cancer
GB0509730D0
Therapeutic agents
AU4430701A
Compounds for targeting
EP1930340A1
Antiproliferative activity of G-rich oligonucleotides and method of using the same to bind to nucleolin
GB0008049D0
Compounds for targeting
GB0007343D0
Compounds for targeting
JPH10259195A
Synthetic peptide to be used in detection of thrombosis
